Hologic's Genius AI Detection Shows Value by Spotting Missed CancersZacks Investment Research • 12/17/25
Hologic's AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening ExamsBusiness Wire • 12/16/25
HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026?Zacks Investment Research • 12/08/25
Hologic's BCI Test Shows Growing Impact in Endocrine Therapy DecisionsZacks Investment Research • 12/04/25
New Data to be Presented at the 2025 SABCS Demonstrates Potential Expanded Utility of the Breast Cancer Index Test, the Leading Biomarker in Personalizing Endocrine Therapy DurationBusiness Wire • 12/02/25
HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet?Zacks Investment Research • 11/27/25
New Clinical Evidence Bolsters Hologic's Breast Cancer TechnologiesZacks Investment Research • 11/26/25
New Clinical Evidence on Hologic's AI-Powered Mammography Solutions Will Be Unveiled at RSNABusiness Wire • 11/25/25
Hologic's GYN Surgical Delivers a Standout Quarter: What's Behind It?Zacks Investment Research • 11/21/25
Hologic Expands European Reach of Genius Digital Diagnostics SystemZacks Investment Research • 11/13/25
HOLX Stock Up on Q4 Earnings & Revenue Beat, Operating Margin ExpandsZacks Investment Research • 11/04/25
Hologic (HOLX) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 11/04/25
HOLX vs. ABT: Which Medical Technology Stock Is the Better Investment?Zacks Investment Research • 10/30/25
HOLX Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Hologic to Blackstone and TPGGlobeNewsWire • 10/29/25
Gear Up for Hologic (HOLX) Q4 Earnings: Wall Street Estimates for Key MetricsZacks Investment Research • 10/29/25
Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLXBusiness Wire • 10/22/25